AC Immune (ACIU) Times Interest Earned (2015 - 2026)
AC Immune (ACIU) posted quarterly Times Interest Earned of $227.51 for Q1 2026, down 36.58% year-over-year from $358.7 in Q1 2025, and up 434.23% quarter-over-quarter from $42.59 in Q4 2025.
AC Immune (ACIU) Times Interest Earned (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Times Interest Earned for 12 consecutive years, with $227.51 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned fell 36.58% year-over-year to $227.51; the TTM figure through Mar 2026 stood at $129.08 (down 78.02% YoY), while the FY2025 annual figure was $362.92, down 7.85% from the prior year.
- Times Interest Earned advanced to $227.51 in Q1 2026 per ACIU's latest filing, from $42.59 in the prior quarter.
- Across five years, Times Interest Earned topped out at $631.33 in Q2 2023 and bottomed at -$18697.0 in Q4 2022.
- Historically, Times Interest Earned has averaged -$908.86 across 5 years, with a median of $174.84 in 2022.
- Annual changes were most pronounced in 2022 — Times Interest Earned slumped 13930.75% — and 2024, when it soared 407.73%.
- AC Immune's Times Interest Earned stood at -$18697.0 in 2022, then jumped by 99.94% to -$10.86 in 2023, then tumbled by 5094.11% to -$564.18 in 2024, then soared by 107.55% to $42.59 in 2025, then soared by 434.23% to $227.51 in 2026.
- Business Quant data shows ACIU's Times Interest Earned at $227.51 in Q1 2026, $42.59 in Q4 2025, and $351.43 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.51 |
| Dec 31, 2025 | 42.59 |
| Sep 30, 2025 | 351.43 |
| Jun 30, 2025 | 387.76 |
| Mar 31, 2025 | 358.70 |
| Dec 31, 2024 | -564.18 |
| Sep 30, 2024 | -220.27 |
| Jun 30, 2024 | 616.50 |
| Mar 31, 2024 | 557.44 |
| Dec 31, 2023 | -10.86 |
| Sep 30, 2023 | 594.85 |
| Jun 30, 2023 | 631.33 |
| Mar 31, 2023 | -181.14 |
| Dec 31, 2022 | -18,697.00 |
| Sep 30, 2022 | 174.84 |
| Jun 30, 2022 | 157.61 |
| Mar 31, 2022 | 122.27 |
| Dec 31, 2021 | -133.26 |
| Sep 30, 2021 | 112.06 |
| Jun 30, 2021 | 92.52 |